# Autonomic Determinants of POTS - Pilot1

> **NCT04050410** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 48 (estimated)

## Conditions studied

- Postural Tachycardia Syndrome

## Interventions

- **DRUG:** Moxonidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04050410
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-08-27
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-03-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04050410

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04050410, "Autonomic Determinants of POTS - Pilot1". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04050410. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*